Hyloris Pharmaceuticals SA (EBR: HYL)

Hyloris Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	27.43	30.41	33.46	50.01	64.4	0.21
Short-Term Investments	0.53	0.5	10.47	0.53	0.01	-
Cash & Short-Term Investments	27.96	30.91	43.93	50.54	64.41	0.21
Cash Growth	-29.49%	-29.64%	-13.09%	-21.53%	31317.56%	-92.37%
Accounts Receivable	4.03	3.57	4.13	2.32	0.05	0.06
Other Receivables	0.33	0.24	-	-	0.21	0.28
Receivables	4.36	3.81	4.13	2.32	0.25	0.33
Prepaid Expenses	0.45	0.59	1.75	1.1	1.95	3.2
Total Current Assets	32.77	35.31	49.8	53.96	66.61	3.74
Property, Plant & Equipment	2.12	2.15	1.06	0.3	0.18	0.1
Long-Term Investments	4.76	4.8	4.95	4.53	0.01	-
Other Intangible Assets	3.82	1.77	1.81	1.85	1.51	1.43
Long-Term Accounts Receivable	1.98	1.59	1.31	1.71	-	-
Long-Term Deferred Charges	-	2.06	1.68	1.09	0.87	0.71
Other Long-Term Assets	0	-	0.12	-	-	0.01
Total Assets	45.44	47.68	60.73	63.44	69.18	5.98
Accounts Payable	4.67	3.2	2.3	2.62	1.6	2.87
Accrued Expenses	0.64	0.12	0.07	0.08	0.03	0.06
Short-Term Debt	0.12	-	-	-	0.41	13.13
Current Portion of Long-Term Debt	-	-	-	8.62	-	-
Current Portion of Leases	0.2	0.24	0.14	0.07	0.05	0.04
Current Income Taxes Payable	-	-	-	0.35	0.05	0.05
Other Current Liabilities	3.2	3.2	3.26	3.25	0.01	0
Total Current Liabilities	8.83	6.76	5.77	14.98	2.13	16.15
Long-Term Debt	-	-	-	-	7.89	-
Long-Term Leases	1.57	1.51	0.75	0.11	0.11	0.02
Other Long-Term Liabilities	0.38	0.34	0.3	0.3	-	-
Total Liabilities	10.78	8.61	6.82	15.39	10.12	16.17
Common Stock	0.14	0.14	0.14	0.13	0.13	0.09
Additional Paid-In Capital	121.51	121.51	121.51	103.69	103.69	23.98
Retained Earnings	-84.25	-80.76	-65.38	-54.81	-43.23	-36.08
Comprehensive Income & Other	-2.75	-1.82	-2.36	-0.96	-1.54	1.82
Total Common Equity	34.66	39.07	53.91	48.06	59.06	-10.19
Shareholders' Equity	34.66	39.07	53.91	48.06	59.06	-10.19
Total Liabilities & Equity	45.44	47.68	60.73	63.44	69.18	5.98
Total Debt	1.89	1.75	0.89	8.79	8.45	13.2
Net Cash (Debt)	26.07	29.15	43.04	41.75	55.96	-12.99
Net Cash Growth	-31.35%	-32.26%	3.09%	-25.39%	-	-
Net Cash Per Share	0.92	1.04	1.58	1.62	2.56	-0.90
Filing Date Shares Outstanding	29.04	28	28	25.83	25.83	17.8
Total Common Shares Outstanding	29.04	28	28	25.83	25.83	17.8
Working Capital	23.94	28.55	44.03	38.98	64.48	-12.41
Book Value Per Share	1.19	1.40	1.93	1.86	2.29	-0.57
Tangible Book Value	30.84	37.3	52.1	46.2	57.55	-11.61
Tangible Book Value Per Share	1.06	1.33	1.86	1.79	2.23	-0.65

Source: S&P Capital IQ. Standard template. Financial Sources.